CD40LG and type 1 diabetes mellitus: In this context, previous studies have observed a reduction in antigen-specific IgD+IgM−/low naïve B cells in patients with autoimmune thyroid disease, type 1 diabetes, and systemic lupus erythematosus [21,22,23].